A large Harvard prospective study (68,786 women and 41,701 men, followed for 30 years) found that consuming two or more servings of avocado per week was associated with a 16% lower risk of cardiovascular disease and a 21% lower risk of coronary heart disease compared to non-consumers. Substituting half a serving of avocado for an equivalent amount of margarine, butter, eggs, yogurt, or processed cheese was associated with a 16–22% lower CVD risk.
RCTs confirm mechanistic benefits: a 2025 GRADE meta-analysis found avocado supplementation significantly reduced total cholesterol, LDL cholesterol, and triglycerides compared to controls. An earlier meta-analysis specifically found a small but significant reduction in total cholesterol (−5.08 mg/dL) in avocado groups. One well-cited RCT showed that adding avocado to a moderate-fat diet reduced LDL particle number and small, dense LDL particles, a marker more predictive of cardiovascular risk than standard LDL levels alone.
Avocados are high in oleic acid and other dietary fats that significantly enhance the absorption of fat-soluble vitamins (A, D, E, K) and carotenoids (beta-carotene, lycopene, lutein) from co-consumed vegetables. Adding avocado or avocado oil to a salad can increase carotenoid absorption from vegetables by 2–15 fold. This makes avocado a particularly useful addition to vegetable-heavy meals.
Avocado consumption does not negatively impact body weight despite its relatively high calorie density, evidence from multiple RCTs shows body weight remains neutral when avocados replace other foods rather than being added on top of the diet. The fiber content (approximately 7g per half avocado) supports satiety and gut microbiome diversity, and the monounsaturated fat profile is associated with improved insulin sensitivity in observational research.
A 2025 ancillary study of the HAT randomized controlled trial (1,008 adults with abdominal obesity, 26 weeks) found that daily avocado consumption significantly increased gut microbial diversity, reflected in both alpha and beta diversity indices, and selectively enriched Faecalibacterium prausnitzii, a short-chain fatty acid (SCFA) producer associated with reduced intestinal inflammation. Benefits were most pronounced in participants with lower baseline diet quality, suggesting avocado may be especially valuable for those with poorer dietary patterns. A second HAT ancillary study (969 adults, 26 weeks) found that daily avocado consumption improved Life’s Essential 8 component scores for diet quality, sleep health, and blood lipids, though overall cardiovascular health score did not reach statistical significance.
Avocados contain beta-sitosterol and other phytosterols that inhibit inflammatory signaling pathways, as well as oleic acid which activates PPAR-alpha, a regulator that dampens inflammatory gene expression. Avocado-soybean unsaponifiables (ASU), a specific extract, have been studied in the context of osteoarthritis and shown anti-inflammatory effects on joint tissue in clinical trials.